ArticlePDF Available

Is C-reactive protein to albumin ratio an indicator of poor prognosis in Bell's palsy?

Authors:

Abstract and Figures

Purpose The aim of this study was to determine whether the C-reactive protein to albumin ratio was associated with the prognosis in patients with Bell’s palsy. Methods Reviewing records of 79 patients diagnosed with Bell’s palsy, 3 groups were constituted: recovered group (with a House Brackman grade of 1 or 2 after treatment, 56 patients), unrecovered group (23 patients) and control group (60 healthy individuals). Age, hemoglobin, C-reactive protein to albumin ratio, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, white blood cell and hemoglobin values were compared among the groups. Results Age, hemoglobin and platelet to lymphocyte ratio were not significantly different between the groups (p = 0.12, p = 0.31, p = 0.86 and p = 0.87, respectively). Median C-reactive protein to albumin ratio, neutrophil to lymphocyte ratio and white blood cell were significantly greater both in non-recovery group (p < 0.001) and recovery group (p = 0.001 and p < 0.001, respectively) compared to the control group. Additionally, median C-reactive protein to albumin ratio and neutrophil to lymphocyte ratio were significantly greater in the non-recovery group, compared to the recovery group (p = 0.002, and p < 0.001, respectively). However, median white blood cell did not significantly differ between the non-recovery and the recovery groups (p = 0.89). Conclusion Higher C-reactive protein to albumin ratio and neutrophil to lymphocyte ratio were associated with poor prognosis in patients with Bell’s palsy. C-reactive protein to albumin ratio might be the most significant indicator of poor prognosis in patients with Bell’s palsy.
This content is subject to copyright. Terms and conditions apply.
Vol.:(0123456789)
1 3
European Archives of Oto-Rhino-Laryngology
https://doi.org/10.1007/s00405-019-05691-3
OTOLOGY
Is C‑reactive protein toalbumin ratio anindicator ofpoor prognosis
inBell’s palsy?
SerkanCayir1 · OmerHizli2 · SerkanKayabasi3
Received: 26 July 2019 / Accepted: 8 October 2019
© Springer-Verlag GmbH Germany, part of Springer Nature 2019
Abstract
Purpose The aim of this study was to determine whether the C-reactive protein to albumin ratio was associated with the
prognosis in patients with Bell’s palsy.
Methods Reviewing records of 79 patients diagnosed with Bell’s palsy, 3 groups were constituted: recovered group (with a
House Brackman grade of 1 or 2 after treatment, 56 patients), unrecovered group (23 patients) and control group (60 healthy
individuals). Age, hemoglobin, C-reactive protein to albumin ratio, neutrophil to lymphocyte ratio, platelet to lymphocyte
ratio, white blood cell and hemoglobin values were compared among the groups.
Results Age, hemoglobin and platelet to lymphocyte ratio were not significantly different between the groups (p = 0.12,
p = 0.31, p = 0.86 and p = 0.87, respectively). Median C-reactive protein to albumin ratio, neutrophil to lymphocyte ratio
and white blood cell were significantly greater both in non-recovery group (p < 0.001) and recovery group (p = 0.001 and
p < 0.001, respectively) compared to the control group. Additionally, median C-reactive protein to albumin ratio and neu-
trophil to lymphocyte ratio were significantly greater in the non-recovery group, compared to the recovery group (p = 0.002,
and p < 0.001, respectively). However, median white blood cell did not significantly differ between the non-recovery and
the recovery groups (p = 0.89).
Conclusion Higher C-reactive protein to albumin ratio and neutrophil to lymphocyte ratio were associated with poor progno-
sis in patients with Bell’s palsy. C-reactive protein to albumin ratio might be the most significant indicator of poor prognosis
in patients with Bell’s palsy.
Keywords Bell’s palsy· Paralysis· C-reactive protein· Albumin· Prognosis
Introduction
Bell’s palsy (idiopathic facial paralysis) is the most common
form of facial nerve paralysis with a rate of 60–75% [1].
Although many factors have been identified in the etiology
of Bell’s palsy, inflammation and viral infections may play
the major role in the pathogenesis. The mechanism of Bell’s
palsy might be based on the inflammatory processes com-
pressing the facial nerve in the fallopian canal [2]. Evidences
reported in the prior literature revealed that Bell’s palsy was
an inflammatory disorder of the facial nerve [35]. Herpes
simplex type 1 genome was detected in endo-neural fluids
and posterior auricular muscles of the patients with Bell’s
palsy [6]. Additionally, this virus was considered to bring
about an inflammation resulting in acute cranial neuropathy
[7]. Moreover, the inflammation of the facial nerve is inter-
related to a novel virus or to the reactivation of a virus that
had already present [8]. Another proof about inflammatory
* Serkan Cayir
drserkancayir@hotmail.com
Omer Hizli
hizliomer@gmail.com
Serkan Kayabasi
drserkankayabasi@gmail.com
1 Department ofENT, Aksaray University, Aksaray Education
andResearch Hospital, 68100Aksaray, Turkey
2 Department ofENT, Giresun University, Prof Dr. A. Ilhan
Ozdemir Education andResearch Hospital, 28200Giresun,
Turkey
3 Department ofENT, Aksaray University, Faculty
ofMedicine, 68100Aksaray, Turkey
European Archives of Oto-Rhino-Laryngology
1 3
etiology is higher neutrophil tolymphocyte ratio (NLR)
values reported in patients with Bell’s palsy. NLR was con-
sidered as a marker of inflammation and also being used to
evaluate the risk of cardiovascular diseases and the prog-
nosis of the patients with cardiovascular diseases and with
various types of cancer [9, 10].
C-reactive protein (CRP) is a positive acute-phase reac-
tant used for diagnosis in patients with infection/inflamma-
tion and for assessment of the efficacy of treatment [11].
Albumin is a negative acute-phase protein. Even though
albumin decreases mainly in acute inflammation, it is known
to decrease also in chronic process of inflammation and in
patients with malnutrition [12]. CRP and albumin may have
a prognostic value together, either in the short term or in the
long term of inflammation [13, 14].
Although the association between NLR and Bell’s palsy
was investigated [15], yet to the best of our knowledge,
thus far, no studies have addressed the association between
C-reactive proteintoalbumin ratio (CAR) and Bell’s palsy.
The goal of this retrospective cross-sectional study was
to determine whether C-reactive protein to albumin ratio
was associated with the prognosis in patients with Bell’s
palsy. We investigated the association of various blood test
parameters including CAR, NLR, and platelet to lymphocyte
ratio (PLR), white blood cell count (WBC) and hemoglobin
(Hbg) with the prognosis of Bell’s palsy.
Materials andmethods
Subjects andstudy design
This retrospective, archival, cross-sectional study was con-
ducted in line with the dictates of the World Medical Asso-
ciation Declaration of Helsinki and approved by the local
ethical committee. We searched the medical archive of our
institution to identify the cases of Bell’s palsy. Excluded
from the study were the patients with any inflammatory and/
or nutritional disease that might affect the level of blood
parameters, facial palsy of central origin, Ramsay–Hunt syn-
drome, traumatic facial palsy, previous history of otologic
surgery or active otologic disease, and the patients who were
admitted 5days (or later) after the first appearance of Bell’s
palsy.
We constituted the study groups from the patients with
Bell’s palsy (with a House Brackman [16] grade over 3 at the
time of first admission), and the control group from healthy
individuals. All patients with Bell’s palsy included in the
study group received corticosteroid treatment (at an initial
dose of prednisone of 1mg/kg/day), with a gradual dose
reduction maintained for at least 2weeks and the patients
were categorized according to the response to the treat-
ment: the recovery group and the non-recovery group. We
considered the patients with a House Brackman grade of 1
or 2 as recovered after receiving the treatment.
Laboratory evaluation
An automated blood cell counter was used for complete
blood count measurements (Mindray BC-6000, Shenzhen,
China). Serum albumin levels were analyzed using Abbott
C8000i (Abbott Park, IL, USA) automatic photometry com-
mercial kits. Serum CRP levels were measured using neph-
elometric method (AU5800 System; Beckman Coulter Inc,
Brea, CA, USA). We noted the blood test parameters includ-
ing Hbg, WBC, CRP, neutrophil count, lymphocyte count,
platelet count and albumin. Then, we calculated CAR, NLR
and PLR values of the study groups and the control group.
First, we compared the CAR, NLR, PLR, WBC, andHbg
of the groups. Then, we investigated the most significant
indicator parameter associated with the poor prognosis of
Bell’s palsy (non-recovery).
Statistical analysis
Results are presented as median (min–max). We inves-
tigated the distribution pattern of the data using Kol-
mogorov–Smirnov normality test (p < 0.05). We used
Kruskal–Wallis test to compare the median CAR, NLR,
WBC, Hbg and PLR values of three groups. For advanced
comparisons of CAR, NLR, WBC, Hbg and PLR, we used
Mann–Whitney U test, as post hoc test. To detect the most
significantly associated parameter with the poor progno-
sis of Bell’s palsy, and to determine a cut-off values, we
used receiving operator characteristics curve (ROC) analy-
sis test. For statistical analysis of all data, we used SPSS
software for Windows (SPSS Inc., Chicago, IL, USA). A p
value less than 0.05 was considered statistically significant.
Additionally, for post hoc comparison tests, we used Bonfer-
roni correction of three groups (triple combination) and a p
value less than 0.017 (0.05/3) was considered statistically
significant.
Results
One hundred thirty-nine individuals were eligible for this
study. Non-recovery group consisted of 23 patients (9 males
and 14 females, mean age 49 ± 3 years) with a non-recov-
ered Bell’s palsy, recovery group consisted of 56 patients
(27 males and 29 females, mean age 49 ± 3years) with a
recovered Bell’s palsy, and the control group consisted of
60 healthy individuals (29 males and 31 females, mean age
50 ± 3). The groups were age-matched (p = 0.06).
The median values of CAR, NLR, PLR, WBC and
Hbg are presented in the Table1. In the Kruskal–Wallis
European Archives of Oto-Rhino-Laryngology
1 3
test, the median Hbg and PLR values did not significantly
differ among three groups (p = 0.86 and p = 0.87, respec-
tively). However, a significant difference of median CAR
(p < 0.001), NLR (p < 0.001) and WBC (p < 0.001) was evi-
dent among three groups.
In post hoc comparisons, median CAR, NLR and WBC
values were significantly greater both in non-recovery group
(p < 0.001) and recovery group (p = 0.001 and p < 0.001,
respectively) compared to the control group (Table1). Addi-
tionally, median CAR and NLR values were significantly
greater in the non-recovery group, compared to the recov-
ery group (p = 0.002, and p < 0.001, respectively). However,
median WBC did not significantly differ between the non-
recovery and the recovery group (p = 0.89) (Table1). Thus,
we found that WBC was not associated with the recovery
of Bell’s palsy, while CAR and NLR might be associated.
Figure1 represents the graph of the ROC analysis of the
parameters included CAR, NLR and WBC. ROC analysis
of poor prognosis of Bell’s palsy revealed that, CAR had a
greater AUC value (0.831) compared to NLR (0.785) and
WBC (0.723) (p < 0.001 and p = 0.001). Thus, CAR might
be an indicator parameter for poor prognosis in Bell’s palsy.
The cut-off value of CAR for poor prognosis in Bell’s palsy
was found as 0.82, with a sensitivity of 95% and specificity
of 78%.
Discussion
Bell’s palsy is identified as a sudden paresis/paralysis of all
facial muscles on one side of the face. Patients with Bell’s
palsy have several complaints such as dry eye, pain around
the ear, altered sense of taste and tear reduction not asso-
ciated with any other cranial neuropathy [17]. The annual
incidence of Bell’s palsy is 15–20 per 100,000 with 40,000
new cases each year. The recurrence rate of Bell’s palsy is
8–12%. There is no gender or racial preference and palsy
can occur at any age, but more cases are seen in mid- and
late life. Risk factors include diabetes mellitus, pregnancy,
preeclampsia, obesity, and hypertension [18].
Even though the pathophysiology of Bell’s palsy is still
unclear, ischemic neuropathy, autoimmune diseases, and
viral inflammation of the facial nerve were suspected. The
viral inflammatory/immune mechanism was considered to
play the major role in the pathogenesis of Bell’s palsy [19].
Inflammatory changes due to the viral infection may result in
edema of the facial nerve in the facial canal, compressing the
nerve and causing the paralysis. Vein reflux occurs owing
to increased pressure on the facial nerve, the congestion of
blood vessels causes edema and compression, as a result of
the ischemia of the facial nerve which is an important factor
related to poor prognosis in patients with facial paralysis
[20].
NLR and the CAR were reported to have prognostic value
as markers of inflammation [14, 15]. NLR, a novel potential
marker for identifying inflammation in various diseases, is
a valuable, easily accessible and inexpensive parameter like
the high-cost inflammatory markers such as IL-6, IL-1b,
Table 1 Comparison of the median values of CAR, NLR, PLR, WBC and Hbg
CAR C-reactive protein to albumin ratio, NLR neutrophil to lymphocyte ratio, PLR platelet to lymphocyte ratio, WBC white blood cell count,
Hbg hemoglobin
* of Kruskal–Wallis test
CAR NLR PLR WBC (×1000/ml) Hbg (mg/Dl)
Non-recovery20.89 (0.82–1.27) 2.9 (1.5–3) 136.3 (115–141.4) 8.76 (8.12–9.38) 14 (13.7–14.2)
Recovery10.71 (0.25–1.3) 1.95 (1.7–2.8) 135.7 (79–149.6) 8.84 (7.96–9.64) 14 (12.7–15.4)
Control00.62 (0.18–1.12) 1.75 (1.65–2.8) 137.3 (108.5–152.6) 6.12 (6.01–8.98) 14 (13.5–14.6)
p value* < 0.001 < 0.001 0.87 < 0.001 0.86
p2–0 < 0.001 < 0.001 < 0.001
p1–0 0.001 < 0.001 < 0.001
p2–1 0.002 < 0.001 0.89 –
Fig. 1 The graph of the ROC analysis
European Archives of Oto-Rhino-Laryngology
1 3
IL-8 and TNF-α [15, 21]. Neutrophils are important for
cytokine production and usually increases in inflammatory
disorders, but a reduction in the number of lymphocytes is
possible during inflammation [22, 23]. NLR may provide
an information about whether the present pathology was a
result of an inflammatory event. Consistent with the prior
literature, we found the median NLR significantly higher in
patients with Bell’s palsy compared to the control group.
Additionally, our results showed that recovery of Bell’s
palsy resulted in a significant NLR decrease.
CRP is a well-known acute-phase protein produced by
hepatocytes in response to cytokines during inflammatory
processes, and significantly increases due to the infection
and inflammation. Increase in CRP levels usually depends
on the severity of the inflammation or infection [24]. On
the other hand, albumin is a negative acute-phase protein
providing an insight into the prognosis of diseases related to
infection and inflammation, and is associated with oxidative
stress [25]. Many prior studies demonstrated the prognos-
tic value of CAR in different cancer types and inflamma-
tory disorders [13, 14]. In this study, we found significantly
greater CAR values in patients with Bell’s palsy compared
to the control group. Based on our results, greater CAR
values might be an indicator of the inflammatory base of
Bell’s palsy. Additionally, CAR values showed a significant
decrease in patients with a recovered disease after receiving
a corticosteroid treatment. Thus, we can hypothesize that
extremely increased levels of CAR might be an indicator
of poor prognosis in patients with Bell’s palsy. Moreover,
the ROC analysis in our study provided the cut off value of
CAR for poor prognosis as 0.82 with a sensitivity of 95%
and specificity of 78%. Thus, physicians could consider the
patients with a CAR value over 0.82 as associated with poor
prognosis.
Our results showed the association of Bell’s palsy not
only with CAR values, but also with NLR values and WBC
levels. However, the WBC was not significantly associated
with recovery. In addition, higher NLR might also be an
indicator of poor prognosis in patients with Bell’s palsy, but
CAR had a greater area under curve in the ROC analysis.
This result suggests that CAR might be a more precious
parameter related to the poor prognosis in patients with
Bell’s palsy.
To the best of our knowledge, this is the first study inves-
tigating the predictive value of CAR in patients with Bell’s
palsy and providing a cut off value for poor prognosis. How-
ever, the major limitation was the retrospective nature of
the study, since we had to include only a limited number
of parameters obtained from the medical records of the
patients. Nevertheless, this study may provide an inspiration
for further prospective investigations of many other blood
test parameters associated with inflammation in patients with
Bell’s palsy.
Conclusion
In conclusion, higher CAR and NLR were associated
with poor prognosis in patients with Bell’s palsy. CAR
might be the most significant indicator of poor prognosis
in patients with Bell’s palsy and physicians could consider
the patients with a CAR value over 0.82 as associated with
poor prognosis.
Author contributions SC: collected and analyzed data, wrote article,
approved the final version. OH: designed and supervised study, inter-
preted data, made statistics, wrote and revised article, approved the
final version. SK: collected and analyzed data, revised article, approved
the final version
Funding The authors declared that this study has received no financial
support.
Compliance with ethical standards
Conflict of interest The authors have no conflict of interest to declare.
References
1. Holland NJ, Weiner GM (2004) Recent developments in Bell’s
palsy. BMJ 329(7465):553–557
2. Kefalidis G, Riga M, Argyropoulou P, Katotomichelakis M,
Gouveris C, Prassopoulos P, Danielides V (2010) Is the width of
the labyrinthine portion of the fallopian tube implicated in the
pathophysiology of Bell’s palsy?: a prospective clinical study
using computed tomography. Laryngoscope 120(6):1203–1207
3. Turriziani O, Falasca F, Maida P, Gaeta A, De Vito C, Man-
cini P, De Seta D, Covelli E, Attanasio G, Antonelli G (2014)
Early collection of saliva specimens from Bell’s palsy patients:
quantitative analysis of HHV-6, HSV-1, and VZV. J Med Virol
86(10):1752–1758
4. Peitersen E (2002) Bell’s palsy: the spontaneous course of 2,500
peripheral facial nerve palsies of different etiologies. Acta Oto-
laryngol 122(7):4–30
5. Song MH, Kim J, Jeon JH, Cho CI, Yoo EH, Lee W-S, Lee H-K
(2008) Clinical significance of quantitative analysis of facial
nerve enhancement on MRI in Bell’s palsy. Acta Otolaryngol
128(11):1259–1265
6. Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N,
Yanagihara N (1996) Bell palsy and herpes simplex virus: iden-
tification of viral DNA in endoneurial fluid and muscle. Ann
Intern Med 124(1_Part_1):27–30
7. Hah YM, Kim SH, Jung J, Kim SS, Byun JY, Park MS, Yeo
SG (2018) Prognostic value of the blink reflex test in Bell’s
palsy and Ramsay–Hunt syndrome. Auris Nasus Larynx
45(5):966–970
8. Furuta Y, Ohtani F, Chida E, Mesuda Y, Fukuda S, Inuyama Y
(2001) Herpes simplex virus type 1 reactivation and antiviral
therapy in patients with acute peripheral facial palsy. Auris Nasus
Larynx 28:S13–S17
9. Mascarella MA, Mannard E, Silva SD, Zeitouni A (2018) Neutro-
phil-to-lymphocyte ratio in head and neck cancer prognosis: a sys-
tematic review and meta-analysis. Head Neck 40(5):1091–1100
European Archives of Oto-Rhino-Laryngology
1 3
10. Xu N, Tang XF, Yao Y, Zhao X, Chen J, Gao Z, Yang Y, Gao RL,
Xu B, Yuan JQ (2018) Predictive value of neutrophil to lympho-
cyte ratio in long-term outcomes of left main and/or three-vessel
disease in patients with acute myocardial infarction. Catheter Car-
diovasc Interv 91(S1):551–557
11. Póvoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira
P, Sabino H (2005) Pilot study evaluating C-reactive protein levels
in the assessment of response to treatment of severe bloodstream
infection. Clin Infect Dis 40(12):1855–1857
12. Don BR, Kaysen G (2004) Poor nutritional status and inflamma-
tion: serum albumin: relationship to inflammation and nutrition.
In: Seminars in dialysis, vol 6. Wiley Online Library, Hoboken,
pp432–437
13. Qin G, Tu J, Liu L, Luo L, Wu J, Tao L, Zhang C, Geng X, Chen
X, Ai X (2016) Serum albumin and C-reactive protein/albumin
ratio are useful biomarkers of Crohn’s disease activity. Med Sci
Monit 22:4393–4400
14. Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K,
Fushiya N, Koike K, Nishino H, Matsushima M (2015) The
C-reactive protein/albumin ratio, a novel inflammation-based
prognostic score, predicts outcomes in patients with hepatocel-
lular carcinoma. Ann Surg Oncol 22(3):803–810. https ://doi.
org/10.1245/s1043 4-014-4048-0
15. Atan D, Ikinciogullari A, Koseoglu S, Ozcan KM, Cetin MA,
Ensari S, Dere H (2015) New predictive parameters of Bell’s
Palsy: neutrophil to lymphocyte ratio and platelet to lymphocyte
ratio. Balkan Med J 32(2):167–170. https ://doi.org/10.5152/balka
nmedj .2015.15456
16. House JW (1983) Facial nerve grading systems. Laryngoscope
93(8):1056–1069
17. Greco A, Gallo A, Fusconi M, Marinelli C, Macri G, De Vincen-
tiis M (2012) Bell’s palsy and autoimmunity. Autoimmun Rev
12(2):323–328
18. Zhao H, Zhang X, Zhu J, Wang X-h, Li S-t (2017) Bell’s palsy:
clinical analysis of 372 cases and review of related literature. Eur
Neurol 77(3–4):168–172
19. May M, Klein S (1991) Differential diagnosis of facial nerve
palsy. Otolaryngol Clin N Am 24(3):613–645
20. Fisch U, Esslen E (1972) Total intratemporal exposure of the
facial nerve: pathologic findings in Bell’s palsy. Arch Otolaryngol
95(4):335–341
21. Turkmen K, Guney I, Yerlikaya FH, Tonbul HZ (2012) The rela-
tionship between neutrophil-to-lymphocyte ratio and inflamma-
tion in end-stage renal disease patients. Ren Fail 34(2):155–159.
https ://doi.org/10.3109/08860 22X.2011.64151 4
22. Wang J, Arase H (2014) Regulation of immune responses by neu-
trophils. Ann NY Acad Sci 1319(1):66–81
23. Moodley D, Mody GM, Chuturgoon AA (2011) Initiation but no
execution-modulation of peripheral blood lymphocyte apoptosis
in rheumatoid arthritis—a potential role for heat shock protein 70.
J Inflamm 8(1):30
24. Luan Y-y, Yao Y-m (2018) The clinical significance and potential
role of C-reactive protein in chronic inflammatory and neurode-
generative diseases. Front Immunol 9:1302
25. Oduncu V, Erkol A, Karabay CY, Kurt M, Akgün T, Bulut M,
Pala S, Kirma C (2013) The prognostic value of serum albumin
levels on admission in patients with acute ST-segment elevation
myocardial infarction undergoing a primary percutaneous coro-
nary intervention. Coron Artery Dis 24(2):88–94
Publisher’s Note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
... [1] Many studies have explored factors related to Bell's palsy prognosis, including age, the severity of initial facial paralysis, diabetes, hypertension, dyslipidemia, and body mass index. [3,4] Biomarkers including C-reactive protein to albumin ratio, [5] white blood cell count, [5,6] neutrophil to lymphocyte ratio [6,7] were also reported to be associated with the recovery of BP. ...
... [1] Many studies have explored factors related to Bell's palsy prognosis, including age, the severity of initial facial paralysis, diabetes, hypertension, dyslipidemia, and body mass index. [3,4] Biomarkers including C-reactive protein to albumin ratio, [5] white blood cell count, [5,6] neutrophil to lymphocyte ratio [6,7] were also reported to be associated with the recovery of BP. ...
... [23] Albumin is thought to be a negative acute-phase protein. [5] In an inflammatory state, vascular endothelial permeability increases. Various components in blood vessels, including albumin, leak out into the tissue space, resulting in decreased albumin concentration in plasma. ...
Article
Full-text available
To investigate the correlation between the serum albumin level and the prognosis of patients with Bell's palsy. We retrospectively analyzed the clinical records of 311 inpatients with Bell's palsy (BP) in our hospital between September 2018 and October 2019. The patients were divided into 2 groups: the recovered group (with the House-Brackmann grade ≤ 2) and the unrecovered group (with the House-Brackmann grade > 2), according to the follow-up results within 3 months after discharge. Blood test indicators (white blood cell count, neutrophil-to-lymphocyte ratio, red cell distribution width, serum albumin level, globulin level) and basic clinical data (age, sex, course of the disease, inpatient days, comorbidity of hypertension, diabetes, and hepatitis B) of the 2 groups were compared to explore whether they were correlated with the prognosis of patients with Bell's palsy. The serum albumin level of patients with BP in the unrecovered group was significantly lower than that of the recovered group (medians [interquartile range], 40.75 [38.40, 43.85] vs 44 [42.10, 46.20], P < .001). Multivariate binary logistic regression revealed that serum albumin (odds ratio 0.772, 95% confidence interval 0.711–0.839, P < .001) was a protective factor for BP prognosis. Serum albumin is a protective factor for the prognosis of BP. Although more prospective clinical controlled trials are needed, our study provides valuable and crucial prognostic information for physicians.
... Several previous studies considered a high inflammatory level a poor prognostic factor for facial palsy [11,12]. C-reactive protein (CRP) is a positive acute-phase inflammatory biomarker, and albumin is a negative acute-phase protein. ...
... The pathophysiology of idiopathic facial palsy remains unclear; it is considered that an inflammatory mechanism is a major contributor to the disease pathogenesis. Cayir et al. [11] reported that higher CAR and NLR levels were associated with poor prognoses in patients with Bell's palsy. Our study did not find significant differences in laboratory data (CAR, NLR, and WBC count) between the two groups in the univariate analysis or logistic regression model. ...
Article
Objective: To examine the prognostic value of electroneuronography (ENoG) in predicting functional recovery in severe cases of acute facial palsy. Methods: Patients with severe degrees of facial palsy (initial House-Brackmann [HB] grades IV to VI) with available electrodiagnostic studies conducted 2-4 weeks after symptom onset were reviewed retrospectively. The patients were categorized into "good recovery" and "poor recovery" groups, with the former showing mild to no dysfunction (HB I to III) and the latter exhibiting moderate to severe dysfunction (HB IV to VI) on follow-up evaluation, 2 months after onset. ENoG amplitudes in four facial muscles (frontalis, nasalis, orbicularis oculi, and orbicularis oris), as well as age, sex, affected side, disease etiology, comorbidities, and laboratory findings, were compared between the two groups. Results: Thirty-seven patients were included. Twenty-nine of the patients showed "good recovery," and eight showed "poor recovery" at 2 months after symptom onset. Univariate analysis yielded no significant difference in age, sex, affected side, disease etiology, comorbidities, and laboratory findings between the two groups. Preserved ENoG amplitudes (individual, average, and trimmed means) were significantly higher in the good recovery group than in the poor recovery group (p<0.005). Sex (p=0.038) and the ENoG of the nasalis muscle, acquired 2-4 weeks from symptom onset (p=0.004), showed significant differences in multivariate regression analysis. Conclusion: This study suggests that the female sex and lower ENoG of the nasalis muscle, acquired 2-4 weeks from symptom onset, have negative prognostic value for the 2-month functional outcome of severe facial palsy cases.
... CRP levels increase depending on the severity of inflammation and infection (19), and albumin as a negative acute-phase protein related to oxidative stress, provides an idea about diagnosing infection and inflammatory complications (20). In a previous study, a significantly higher CRP/albumin ratio was determined in patients with Bell's palsy than in the control group, and CRP/albumin ratio was also significantly higher in unrecovered patients (21). In our study, the CRP/albumin ratio was statistically significantly higher in the patient group than in the control group. ...
... Bucak et al. 5 showed that NLR levels were significantly higher in patients with Bell's palsy, and patients with unsatisfactory recovery had higher NLR levels. Similar to that study, Cayir et al. 21 stated an association between high NLR levels and poor prognosis. Conversely, Horibe et al. 25 claimed that NLR was not a significant marker. ...
Article
Full-text available
Aim: Bell's palsy is a form of deficiency in the face and paralysis related to peripheral- nerve dysfunction. Our study investigates the role of the inflammatory values in predicting Bell’s palsy prognosis. Methods: A total of 58 Bell’s palsy ≥ III patients, according to the House Brackman classification, on the first presentation were taken as the study group, and 60 age and gender-matched healthy people without any disease formed the control group. The success of the corticosteroid treatment was accepted as House Brackmann grades I and II in the post-treatment follow-up, and grades III to VI patients were evaluated as partial-not meaningful recovery. In addition, pretreatment hemogram and biochemistry tests were recorded, and the C-reactive protein (CRP)/albumin ratio, Neutrophil to lymphocyte ratio (NLR), red blood cell distribution width (RDW), and mean platelet volume (MPV) of the patients were compared. Results: In the study group, the CRP/albumin ratio and the mean RDW were statistically significantly higher than the control group (0.958 ± 0.91 vs. 0.478 ± 0.322, p = 0.029; 13.89 ± 1.27 vs. 12.98 ± 0.72, p 0.05). Conclusion: Higher CRP/albumin, RDW, NLR, MPV were related to a poor prognosis for Bell’s palsy. RDW, which to date has been a widely used marker for inflammation, could be a potentially promising marker for use in predicting prognosis in Bell’s palsy.
... During the past decade, several inflammation-based prognostic systems have been reported in the field of clinical oncology (5). Neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), platelet (PLT) and mean platelet volume (MPV) are the most popular ones. ...
... Neutrophil, lymphocyte, CRP and PLT counts, either as individual values or in relation to each other, could be associated with the cancer prognosis (17)(18)(19)(20). NLR and the CAR were reported to have a significantly prognostic value as the markers of inflammation (5,18,19). NLR, a novel potential marker for identifying inflammation in various diseases, is a valuable marker, easily accessible and cheap parameter unlike the expensive inflammatory markers such as IL-6, IL-1b. Ozyalvacli et al. (20) have reported that high NLR is a significant diagnostic factor of distinction of breast cancer. ...
Article
Full-text available
ABSTRACT Introduction: During the past decade, several inflammation-based prognostic systems have been reported in the field of clinical oncology. Recently, C-reactive protein (CRP) and albumin ratio (CAR) have showed their impact on a large variety of tumor types. The aim of this study is to evaluate the impact CAR on prognosis and 5 year survival in patients operated for larynx cancer. Methods: The impact of the CAR and NLR on the 5-year survival were evaluated 118 patients operated in our center between 2010 and 2015 were eligible for retrospective analysis. Univariate and multivariate Cox regression analysis were performed to determine the associations of CAR. Results: The optimal cutoff level of CAR was at 0.993. A low and high CAR was assigned to 40.7% and 59.3% of patients, respectively. The 5 year survival rates of patients with a high CAR was worse than those in the low group (79.2% vs 73.2% p <0.05). Disease stage (p < 0.001), and NLR were also significant predictors of 5yS. CAR at diagnosis was associated with an unfavorable progress. Patients with Stage III-IV disease had a significantly higher pretreatment CAR (1.83±0.52) than patients with Stage I-II disease (0.58±0,38; P < 0.01). ROC analysis of overall survival of LSCC revealed that, CAR had a greater (area under curve) AUC value (0.786) compared to NLR (0.695) (p < 0.01) Conclusion: CAR is an independent prognostic marker in larynx cancer after adjusted by other accompanying factors and the CAR could be a readily available biomarker in clinical setting.
... To date, the CAR has been linked with the severity and poor outcomes of various conditions, including sepsis [7], cancer [68][69][70][71][72][73], cardiovascular diseases [74,75], abdominal aortic aneurysm [76], aneurysmal subarachnoid haemorrhage [77], AIDS-related pneumocystis pneumonia [78], acute pancreatitis [79], carotid artery stenosis [80], Guillain-Barré syndrome [81], Bell's palsy [82], and primary and secondary myelofbrosis [83]. Notably, the CAR is simpler to calculate and easier to obtain than other rating standards, making it a crucial tool for quickly assessing patients' conditions in emergency environments [84,85]. ...
Article
Full-text available
Sepsis is a leading cause of mortality among severely ill individuals, primarily due to its potential to induce fatal organ dysfunction. For clinicians, it is vital to have appropriate indicators, including the physiological status and personal experiences of patients with sepsis, to monitor the condition and assess prognosis. This approach aids in preventing the worsening of the illness and reduces mortality. Recent guidelines for sepsis focus on improving patient outcomes through early detection and timely treatment. Nonetheless, identifying severe cases and predicting their prognoses remain challenging. In recent years, there has been considerable interest in utilising the C-reactive protein (CRP)/albumin ratio (CAR) to evaluate the condition and forecast the prognosis of patients with sepsis. This research concentrates on the significance of CAR in the pathological process of sepsis, its association with prognosis, and the latest developments in employing procalcitonin, lactic acid, CRP, and other potential biomarkers. The CAR, with its predictive value for sepsis prognosis and mortality, is increasingly used as a clinical biochemical marker in diagnosing and monitoring patients with sepsis.
... For instance, Bell's palsy patients exhibit significantly higher levels of IL-6, IL-8, and TNF-α compared to those in healthy controls [29]. Furthermore, an elevated CRP to albumin ratio and an increased neutrophil to lymphocyte ratio have been linked to a poor prognosis in patients with Bell's palsy [30]. Prior study has shown that individuals with anxiety disorders are at an increased risk of developing Bell's palsy (HR = 1.53, 95% CI = 1.21-1.94) ...
Article
Full-text available
Background Prior studies have reported a potential relationship between depressive disorder (DD), immune function, and inflammatory response. Some studies have also confirmed the correlation between immune and inflammatory responses and Bell’s palsy. Considering that the pathophysiology of these two diseases has several similarities, this study investigates if DD raises the risk of developing Bell’s palsy. Methods This nationwide propensity score-weighting cohort study utilized Taiwan National Health Insurance data. 44,198 patients with DD were identified as the DD cohort and 1,433,650 adult subjects without DD were identified as the comparison cohort. The inverse probability of treatment weighting (IPTW) strategy was used to balance the differences of covariates between two groups. The 5-year incidence of Bell’s palsy was evaluated using the Cox proportional-hazard model, presenting results in terms of hazard ratios (HRs) and 95% confidence intervals (CIs). Results The average age of DD patients was 48.3 ± 17.3 years, and 61.86% were female. After propensity score-weighting strategy, no significant demographic differences emerged between the DD and comparison cohort. The Cox proportional hazards model revealed a statistically significant adjusted IPTW-HR of 1.315 (95% CI: 1.168–1.481) for Bell’s palsy in DD patients compared to comparison subjects. Further independent factors for Bell’s palsy in this model were age (IPTW-HR: 1.012, 95% CI: 1.010–1.013, p < 0.0001), sex (IPTW-HR: 0.909, 95% CI: 0.869–0.952, p < 0.0001), hypertension (IPTW-HR: 1.268, 95% CI: 1.186–1.355, p < 0.0001), hyperlipidemia (IPTW-HR: 1.084, 95% CI: 1.001–1.173, p = 0.047), and diabetes (IPTW-HR: 1.513, 95% CI: 1.398–1.637, p < 0.0001) Conclusion This Study confirmed that individuals with DD face an elevated risk of developing Bell’s palsy. These findings hold significant implications for both clinicians and researchers, shedding light on the potential interplay between mental health and the risk of certain physical health outcomes.
... Thus, increased infl ammatory markers could be considered as a hallmark fi nding in patients with ICU. On the other hand, CAR is also associated with infl ammatory conditions such as diabetic nephropathy (2), pancreatitis (7), spondyloarthritis (8), neuro-infl ammatory conditions (9,10), and infections (11). All of these conditions are characterized with some degree of infl ammation as is common in the ICU population. ...
Article
Background: Patients in intensive care unit (ICU) require close follow up and clinical attention due to variability in the course of their underlying morbidities. The estimation of prognosis in these subjects has an utmost importance. Recent studies showed that C-reactive protein-to-serum albumin ratio (CAR) could be a reliable marker of inflammation in certain conditions. We aimed to compare CAR levels of deceased patients to those in survived subjects treated in ICU. Patients and methods: We retrospectively analyzed the data of adult patients. CAR was simply calculated by dividing the levels of CRP by those of serum albumin. Patients were grouped either as deceased or survived according to the prognosis. The data of the survived and deceased ICU subjects were compared. Results: A total of 208 subjects, 101 deceased and 107 survived, were enrolled in the study. Median CAR levels of the deceased and survived subjects were 49.5 (3-153 %) and 11 (0.2-119 %), respectively (p < 0.001). CAR was significantly correlated with PDW (r = 0.24; p < 0.001) and serum creatinine (r = 0.27; p < 0.001) levels. In ROC analysis, CAR values higher than 30.2 % have 72 % sensitivity and 70 % specificity in predicting mortality in ICU population (AUC: 0.74; p < 0.001; 95% CI: 0.67-0.81). Conclusions: We suggest that CAR levels of the subjects in ICU should be evaluated during medical care. Increased CAR levels should alert physicians for a worse outcome in those subjects (Tab. 1, Fig. 1, Ref. 21). Text in PDF www.elis.sk Keywords: C-reactive protein-to-serum albumin ratio, intensive care, mortality.
... In a previous study examining the correlation between the C-reactive protein to albumin ratio (CAR) and certain disorders, such as chronic sinusitis, nasal polyposis, various cancers, and inflammatory diseases, CAR was reported as a valuable prognostic parameter [57]. Similarly, one study concluded that CAR, rather than other values, was an indicator of poor BP prognosis [20]. Procalcitonin levels were also significantly correlated with HBS and poor recovery, which may provide important information on facial nerve inflammation [31]. ...
Article
Full-text available
Acute peripheral facial palsy (APFP), including Bell’s palsy and Ramsay Hunt syndrome, is a disease that affects daily life through facial motor dysfunction, causing psychological problems. Various tests to evaluate prognosis have been studied; however, there are no validated predictive biomarkers to guide clinical decision making. Therefore, specific biomarkers that respond to treatment are required to understand prognostic outcomes. In this review, we discuss existing literature regarding the role of APFP biomarkers in prognosis and recovery. We searched the PubMed, EMBASE, and Cochrane Library databases for relevant papers. Our screening identified relevant studies and biomarkers correlating with the identification of predictive biomarkers. Only studies published between January 2000 and October 2021 were included. Our search identified 5835 abstracts, of which 35 were selected. All biomarker samples were obtained from blood and were used in the evaluation of disease severity and prognosis associated with recovery. These biomarkers have been effective prognostic or predictive factors under various conditions. Finally, we classified them into five categories. There is no consensus in the literature on the correlation between outcomes and prognostic factors for APFP. Furthermore, the correlation between hematologic laboratory values and APFP prognosis remains unclear. However, it is important to identify new methods for improving the accuracy of facial paralysis prognosis prediction. Therefore, we systematically evaluated prognostic and potentially predictive APFP biomarkers. Unfortunately, a predictive biomarker validating APFP prognosis remains unknown. More prospective studies are required to reveal and identify promising biomarkers providing accurate prognosis.
Article
BACKGROUND: Bells Palsy (BP), accepted as an idiopathic condition and for which inflammation is believed to have a role in the pathogenesis, is a disease characterized by acute unilateral weakness in facial muscles innervated by the facial nerve. AIM: This study aimed to examine the relationship between the C-reactive protein/albumin ratio (CAR) and hematological parameters including the neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), mean platelet volume (MPV), and red cell distribution width (RDW) in children with BP. MATERIALS AND METHODS: The study included 65 children diagnosed with idiopathic peripheral facial paralysis and a control group of 49 healthy children. The patients were classified into two groups according to the House-Brackmann (HB) grade at the time of diagnosis, as mild (HB grade 23) and severe (HB grade 45). Patients evaluated as HB grade 1 with normal, healthy, and symmetrical muscle function were not included in the study. The children in the patient group were classified into three groups at the end of a six-month follow-up period as full recovery, partial recovery, and no recovery. The patient and control groups were compared according to the CAR, NLR, PLR, MPV, and RDW values. After treatment, the full recovery and no recovery groups were compared based on the CAR, NLR, PLR, MPV, and RDW values. RESULTS: The NLR was found to be significantly higher in the BP patient group than in the control group (p 0.001). There was also a significant difference in the NLR value between the full recovery and no recovery groups. No statistically significant difference was found between the patient and control groups or between the full recovery and no recovery groups in terms of the CAR, PLR, MPV and RDW values. CONCLUSIONS: NLR, an easily accessed hematological parameter, may be used as a marker of poor prognosis in pediatric patients with BP. CAR was of no prognostic value in pediatric BP patients.
Article
Full-text available
AIM The course of infection due to SARS-CoV-2 is manifested by viral replication in the upper respiratory tract with or without lung involvement and extrapulmonary systemic hyperinflammation syndrome. Because it has a wide clinical spectrum ranging from asymptomatic cases to multiorgan failure, early identification of prognostic biomarkers is crucial to distinguish patients at risk of developing more serious disease. Our aim is to investigate the relationship between the biomarker CAR, which has both prognostic and diagnostic importance, and Covid 19 infection. MATERİALS AND METHODS Between 1 June 2021 and 1 September 2021, 215 patients who were followed up in the pandemic service and intensive care unit for Covid 19 pneumonia were retrospectively analyzed. The demographic and routine laboratory data of the patients and the parameters accepted as new inflammatory biomarkers such as NLR, PLR, LMR and CAR were compared between the service-intensive care unit and exitus-discharged groups. RESULTS A total of 205 patients with a diagnosis of Covid 19 pneumonia, 113 (55.1%) male and 92 (44.9%) female, were included in the study. When CAR, known as a new inflammatory biomarker, was compared between both groups, it was found to be statistically significantly higher in patients hospitalized in the intensive care unit (p
Article
Full-text available
C-reactive protein (CRP) is an acute-phase protein synthesized by hepatocytes in response to pro-inflammatory cytokines during inflammatory/infectious processes. CRP exists in conformationally distinct forms such as the native pentameric CRP and monomeric CRP (mCRP) and may bind to distinct receptors and lipid rafts and exhibit different functional properties. It is known as a biomarker of acute inflammation, but many large-scale prospective studies demonstrate that CRP is also known to be associated with chronic inflammation. This review is focused on discussing the clinical significance of CRP in chronic inflammatory and neurodegenerative diseases, such as cardiovascular disease, type 2 diabetes mellitus, age-related macular degeneration, hemorrhagic stroke, Alzheimer’s disease, and Parkinson’s disease, including recent advances on the implication of CRP and its forms specifically on the pathogenesis of these diseases. Overall, we highlight the advances in these areas that may be translated into promising measures for the diagnosis and treatment of inflammatory diseases.
Article
Full-text available
Bell's palsy is the most frequent cause of unilateral facial paralysis. Inflammation is thought to play an important role in the pathogenesis of Bell's palsy. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) are simple and inexpensive tests which are indicative of inflammation and can be calculated by all physicians. The aim of this study was to reveal correlations of Bell's palsy and degree of paralysis with NLR and PLR. Case-control study. The retrospective study was performed January 2010 and December 2013. Ninety-nine patients diagnosed as Bell's palsy were included in the Bell's palsy group and ninety-nine healthy individuals with the same demographic characteristics as the Bell's palsy group were included in the control group. As a result of analyses, NLR and PLR were calculated. The mean NLR was 4.37 in the Bell's palsy group and 1.89 in the control group with a statistically significant difference (p<0.001). The mean PLR was 137.5 in the Bell's palsy group and 113.75 in the control group with a statistically significant difference (p=0.008). No statistically significant relation was detected between the degree of facial paralysis and NLR and PLR. The NLR and the PLR were significantly higher in patients with Bell's palsy. This is the first study to reveal a relation between Bell's palsy and PLR. NLR and PLR can be used as auxiliary parameters in the diagnosis of Bell's palsy.
Article
Objective: This study was designed to evaluate the prognostic value of the blink reflex (BR) test in patients with Bell's palsy (BP) or Ramsay Hunt syndrome (RHS). Methods: The House-Brackmann (HB) grade of patients diagnosed with BP and RHS was determined at first visit and 3 months later. Final HB grade III-VI was defined as an incomplete recovery. Factors evaluated as prognostic of poor recovery included electroneurography (ENoG) degeneration rate (DR)>90%, and absence of BR. Rates of complete and incomplete recovery were calculated and the associations between prognostic factors and recovery were determined. Results: Of the 129 included patients, 98 (76%) had BP and 31 (24%) had RHS. Absence of BR and low mean ENoG value were significantly associated with incomplete recovery in both the BP and RHS groups (p<0.05 each). Initial HB grade V-VI was significantly associated with rate of incomplete recovery in patients with RHS (p<0.05 each). Severe residual palsy (final HB grade V-VI) in the absence of BR was significantly more frequent in patients with RHS than with BP (p<0.05). Conclusion: BR test results were a good prognostic indicator in patients with BP and RHS, as were ENoG value. Absence of BR was more frequently associated with severe residual palsy in RHS than in BP.
Article
Background: Hematologic markers, such as the neutrophil-to-lymphocyte ratio (NLR), characterize the inflammatory response to cancer and are associated with poorer survival in various malignancies. We evaluate the effect of pretreatment NLR on overall survival (OS) in patients with head and neck squamous cell carcinoma (HNSCC). Methods: Using multiple databases, a systematic search for articles evaluating the effect of NLR on OS in patients with HNSCC was performed. An inverse variation, random-effects model was used to analyze the data. Results: A total of 24 of 241 articles, including 6479 patients, were analyzed. The combined hazard ratio for OS in patients with an elevated NLR (range 2.04-5) was 1.78 (confidence interval [CI] 1.53-2.07; P < .0001). The hazard ratios for site-specific cancer: oral cavity 1.56 CI 1.23-1.98 (P < .001), nasopharynx 1.66 CI 1.35-2.04 (P < .001), larynx 1.55 CI 1.26-1.92 (P < .001), and hypopharynx 2.36 CI 1.54-3.61 (P < .001). Conclusion: An elevated NLR is predictive of poorer OS in patients with HNSCC.
Article
Objectives: We sought to evaluate the independent predictive value of left main disease (LMD) and/or three-vessel disease (LMD/3VD) in acute myocardial infarction (AMI) patients. Background: Patients with acute coronary syndrome resulting from LMD and/or three-vessel disease (LMD/3VD) are at the highest risk of adverse cardiovascular events. Neutrophil to lymphocyte ratio (NLR) has been proposed as a marker of cardiovascular risk, but the prognostic value of NLR in patients with LMD/3VD who underwent percutaneous coronary intervention (PCI) is not clearly defined. Methods: Patients (n = 806) admitted with LMD/3VD who underwent PCI between January 2013 and December 2013 were followed up for 2 years. Admission NLR was divided into two sub-groups based on an optimal cut off value predicting 2-year all-cause mortality. The primary end point was all-cause death. The secondary end point was long-term major adverse cardiovascular and cerebrovascular events (MACCE). Results: During follow-up, the high NLR group was associated with a significantly higher rate of long-term all-cause mortality (6.7 vs. 0.9%, P < .001), and MACCE (24.7 vs. 15.8%, P = .002) compared to the low NLR group. In multivariate analysis, after adjusting for risk factors, NLR ≥ 3.39 was determined to be an independent predictor of 2-year all-cause mortality (hazard ratio[HR] 3.08, 95% confidence interval [CI] 1.06 to 8.97, P = .039) and MACCE (hazard ratio 1.44, 95% CI 1.01 to 2.05, P = .046) for LMD/3VD. Conclusions: The admission NLR as relatively inexpensive marker of inflammation may aid in the risk stratification and prognosis of patients diagnosed with LMD/3VD.
Article
Objective: To analyze some clinical and epidemiologic aspects of Bell's palsy (BP) and to develop relevant correlations between existing data in literature and those obtained in this research. Methods: From January 2012 to December 2014, 372 consecutive patients diagnosed with BP were studied retrospectively. We reviewed the patients' data including gender, age, occupation, clinical manifestations, comorbid disease, and the rate of recurrence. Result: The highest incidence was identified in those between 39 and 50 years of age. BP was more frequent in warm seasons (spring and summer) with its incidence reaching a peak value in September. The seasonal incidence of BP was significantly higher in summer (p < 0.05). In addition, diabetes mellitus was the most common accompanying comorbid condition. Conclusion: The peak age when BP showed up was in the fourth decade of life and 55.1% of patients belonged to the male gender. BP has been observed to have the highest incidence during warm seasons (spring and summer). Diabetes mellitus was the most common comorbid condition accompanying BP. In addition, a recurrence was more likely to occur in the first 1.5 years after its first incidence.
Article
Background: Serum albumin (ALB) may be low during acute inflammation, but it is also affected by nutritional status. Therefore, we hypothesized that ALB and the C-reactive protein/ALB ratio (CRP/ALB) may be associated with disease activity in patients with Crohn’s disease (CD). Material/Methods: Altogether, 100 patients with CD and 100 age- and sex-matched healthy volunteers were retrospectively enrolled in the current study. The patients with CD were subdivided into patients with active disease (Crohn’s Disease Activity Index >150) and those in remission. ALB levels, CRP levels, and lipid profiles were measured. Results: ALB and CRP levels and the CRP/ALB ratio were the most useful for differentiating between active and non-active CD. ALB levels (r=-0.50, P<0.01), CRP levels (r=0.39, P<0.01), and CRP/ALB ratio (r=0.42, P<0.01) all correlated with CD activity. These correlations were more prominent in males. Receiver Operating Characteristic (ROC) analysis indicated that the area under the curve (AUC) representing ALB (0.79) was higher than the AUC representing CRP (0.73) or CRP/ALB ratio (0.75; P>0.05). The AUCs corresponding to ALB level, CRP level, and CRP/ALB ratio were more prominent in males versus females (P<0.05). CRP level (14.55 mg/L), ALB level (34.35 g/L), and CRP/ALB ratio (0.69) had sensitivities of 67.7%, 72.6%, and 59.7%, and specificities of 73.7%, 78.9%, and 81.6%, respectively, for CD activity. Conclusions: In the present retrospective study, we found that ALB level and CRP/ALB ratio were useful biomarkers for identifying CD activity, especially in males. These results suggest that, in addition to inflammation, assessment of patient nutritional status could also aid in identifying CD activity.
Article
Background The C-reactive protein/albumin (CRP/Alb) ratio is associated with outcomes in septic patients. We investigated the prognostic value of the CRP/Alb ratio in patients with hepatocellular carcinoma (HCC). Methods We retrospectively evaluated 186 newly diagnosed HCC patients and investigated the correlations among the pretreatment CRP/Alb ratio, clinicopathological parameters, and overall survival (OS). Multivariate analyses were performed to identify the clinicopathological parameters associated with OS. Subsequently, we evaluated the prognostic value of the CRP/Alb ratio compared with other inflammation-based prognostic scores [Glasgow Prognostic Score (GPS), modified GPS (mGPS), and neutrophil lymphocyte ratio (NLR)] using the area under the curve (AUC). Results The optimal cutoff level for the CRP/Alb ratio was 0.037. An elevated CRP/Alb ratio (≥0.037) was associated with tumor progression and reduced liver functional reserve. In the multivariate analysis, the CRP/Alb ratio [hazard ratio (HR) 3.394; p